Skip to main content

Table 2 Estimation of the OCS use (mg) in patients with severe asthma per 100,000 inhabitants, and estimation of the mean OCS use (mg) per patient with severe asthma and with at least one OCS prescription by Spanish region in 2019

From: Geographical differences in the use of oral corticosteroids in patients with severe asthma in Spain: heat map based on existing databases analyses

Region

mg/100,000 inhabitants

mg/patient

Mean

SD

Mean*

Spain

148,479

62,024

1099.85

Andalucía, Ceuta and Melilla

185,682

84,517

1375.42

Aragón

139,255

46,719

1031.52

Asturias

193,406

66,244

1432.64

Cantabria

151,612

54,022

1123.05

Castilla y León

125,784

56,933

931.74

Castilla-La Mancha

138,607

47,553

1026.71

Cataluña

152,360

52,790

1128.59

Comunidad de Madrid

118,311

55,461

876.38

Comunidad Valenciana

141,954

47,347

1051.51

Extremadura

160,772

46,520

1190.90

Galicia

177,671

50,420

1316.08

Islas Baleares

113,766

37,946

842.71

Islas Canarias

145,379

48,979

1076.88

La Rioja

127,735

36,464

946.18

Murcia

151,664

45,337

1123.43

Navarra

105,703

32,111

782.99

País Vasco

120,155

47,445

890.04

  1. *No standard deviation could be calculated because of the methodology used to obtain this figure as explained in methods section: total OCS use during 2019/reference population *0.5% (patients with severe asthma) *27% (patients who had at least one OCS prescription)
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us